The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats
Authors
Keywords
Sodium nitroprusside, Ketamine, Schizophrenia, Anxiety, Rat
Journal
PSYCHOPHARMACOLOGY
Volume 233, Issue 6, Pages 1045-1054
Publisher
Springer Nature
Online
2015-12-19
DOI
10.1007/s00213-015-4181-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia
- (2015) Ludmyla Kandratavicius et al. BMC NEUROSCIENCE
- Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week
- (2015) Joao Paulo Maia-de-Oliveira et al. SCHIZOPHRENIA RESEARCH
- Investigating Glutamatergic Mechanism in Attention and Impulse Control Using Rats in a Modified 5-Choice Serial Reaction Time Task
- (2014) Abigail Benn et al. PLoS One
- The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety
- (2013) Vasilios Grivas et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Nitric Oxide Donors as Neuroprotective Agents after an Ischemic Stroke-Related Inflammatory Reaction
- (2013) Marisol Godínez-Rubí et al. Oxidative Medicine and Cellular Longevity
- Anxiety comorbidity in schizophrenia
- (2013) Raphael J. Braga et al. PSYCHIATRY RESEARCH
- Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice
- (2013) Ana C. Issy et al. PSYCHOPHARMACOLOGY
- Crocins, the active constituents of Crocus Sativus L., counteracted ketamine–induced behavioural deficits in rats
- (2013) Georgia Georgiadou et al. PSYCHOPHARMACOLOGY
- Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside
- (2013) Jaime E. C. Hallak et al. JAMA Psychiatry
- Nitric Oxide and Schizophrenia: Present Knowledge and Emerging Concepts of Therapy
- (2012) Hans-Gert Bernstein et al. CNS & Neurological Disorders-Drug Targets
- Nitric oxide modulates apomorphine-induced recognition memory deficits in rats
- (2012) Ioannis Gourgiotis et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Targeting glutamate synapses in schizophrenia
- (2011) Julie R. Field et al. TRENDS IN MOLECULAR MEDICINE
- Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study
- (2010) Yuichiro Nakano et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Effects of the Nitric Oxide Synthase Inhibitor L-NAME on Recognition and Spatial Memory Deficits Produced by Different NMDA Receptor Antagonists in the Rat
- (2010) Antonios Boultadakis et al. NEUROPSYCHOPHARMACOLOGY
- Oxidative stress in schizophrenia: An integrated approach
- (2010) Byron K.Y. Bitanihirwe et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
- (2010) Joanna C. Neill et al. PHARMACOLOGY & THERAPEUTICS
- Evaluation of NMDA receptor models of schizophrenia: Divergences in the behavioral effects of sub-chronic PCP and MK-801
- (2009) Alexandre Seillier et al. BEHAVIOURAL BRAIN RESEARCH
- Role of ventral hippocampal nitric oxide/cGMP pathway in anxiety-related behaviors in rats submitted to the elevated T-maze
- (2009) A.V. Calixto et al. BEHAVIOURAL BRAIN RESEARCH
- Anxiolytic Effects of Phosphodiesterase-2 Inhibitors Associated with Increased cGMP Signaling
- (2009) A. Masood et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats
- (2009) Larissa de Oliveira et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats
- (2009) Lêda S.B. Garcia et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
- (2008) J. McGrath et al. EPIDEMIOLOGIC REVIEWS
- Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory
- (2008) N. Pitsikas et al. NEUROSCIENCE
- Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls
- (2008) Bun-Hee Lee et al. SCHIZOPHRENIA RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started